Patients Aged <65 Years Face Higher Costs for Treatment of 4 Common Cancers

Tony Berberabe, MPH
Published: Wednesday, Jun 13, 2018
Matthew P. Banegas, PhD, MPH

Matthew P. Banegas, PhD, MPH

Patients younger than 65 years experienced net cancer costs that were higher for breast, colorectal, lung, and prostate cancer compared with patients who were 65 years and older, according to results from a study by the Center for Health Research at Kaiser Permanente Northwest in Portland, Oregon.1 Lead investigator, Matthew P. Banegas, PhD, MPH, said the findings help to fill in the gaps in the literature about cancer care costs, especially in younger populations.

Each of the 4 health plans has a tumor registry and an integrated electronic health record database. These plans provide both private and public health insurance coverage, including Medicare Advantage and Medicaid risk contracts.

Figure. Mean Total and Net Costs of Medical Care for Lung and Prostate Cancer

Figure. Mean Total and Net Costs of Medical Care for Lung and Prostate CancerAdapted from reference 1. Net costs were defined as the difference in mean total costs between patients and controls who were enrolled in 4 health plans.

... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Advances in™ Therapies for Patients With ALK-Positive Lung Cancers: More Options…More Decisions…Better OutcomesAug 30, 20191.5
Community Practice Connections™: PARP Inhibition in Breast Cancer: Practical Methods to Interpret and Apply the Evidence for Your PatientsAug 30, 20191.5
Publication Bottom Border
Border Publication